Migraine and perimenopause

Khatera Ibrahimi; Emile G M Couturier; Antoinette MaassenVanDenBrink

doi:10.1016/j.maturitas.2014.05.018

Migraine and perimenopause

Khatera Ibrahimi
, Emile G M Couturier
, Antoinette MaassenVanDenBrink

Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: [email protected].

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.

Original language	English
Pages (from-to)	277-80
Number of pages	4
Journal	Maturitas
Volume	78
Issue number	4
DOIs	https://doi.org/10.1016/j.maturitas.2014.05.018
Publication status	Published - Aug 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Estrogen Replacement Therapy/adverse effects
Hormones/metabolism
Humans
Menstruation
Migraine Disorders/drug therapy
Perimenopause/metabolism
Stroke/etiology

Access to Document

10.1016/j.maturitas.2014.05.018

Cite this

@article{9626f15d9e684c5f9b6377e5a76b6efb,

title = "Migraine and perimenopause",

abstract = "Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.",

keywords = "Estrogen Replacement Therapy/adverse effects, Hormones/metabolism, Humans, Menstruation, Migraine Disorders/drug therapy, Perimenopause/metabolism, Stroke/etiology",

author = "Khatera Ibrahimi and Couturier, \{Emile G M\} and Antoinette MaassenVanDenBrink",

year = "2014",

month = aug,

doi = "10.1016/j.maturitas.2014.05.018",

language = "English",

volume = "78",

pages = "277--80",

journal = "Maturitas",

issn = "0378-5122",

publisher = "Elsevier Ireland Ltd",

number = "4",

}

TY - JOUR

T1 - Migraine and perimenopause

AU - Ibrahimi, Khatera

AU - Couturier, Emile G M

AU - MaassenVanDenBrink, Antoinette

PY - 2014/8

Y1 - 2014/8

N2 - Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.

AB - Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.

KW - Estrogen Replacement Therapy/adverse effects

KW - Hormones/metabolism

KW - Humans

KW - Menstruation

KW - Migraine Disorders/drug therapy

KW - Perimenopause/metabolism

KW - Stroke/etiology

U2 - 10.1016/j.maturitas.2014.05.018

DO - 10.1016/j.maturitas.2014.05.018

M3 - Review article

SN - 0378-5122

VL - 78

SP - 277

EP - 280

JO - Maturitas

JF - Maturitas

IS - 4

ER -

Migraine and perimenopause

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this